Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MALMSTRÖM, Per")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 72

  • Page / 3
Export

Selection :

  • and

Time to abandon testing for microscopic haematuria in adults?MALMSTRÖM, Per-Uno.BMJ. British medical journal (International ed.). 2003, Vol 326, Num 7393, pp 813-815, issn 0959-8146, 3 p.Article

Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy - 25 year follow-up of a randomised trial from the South Sweden Breast Cancer GroupKILLANDER, Fredrika; ANDERSON, Harald; KJELLEN, Elisabeth et al.European journal of cancer (1990). 2014, Vol 50, Num 13, pp 2201-2210, issn 0959-8049, 10 p.Article

Intravesical therapy of superficial bladder cancerMALMSTRÖM, Per-Uno.Critical reviews in oncology/hematology. 2003, Vol 47, Num 2, pp 109-126, issn 1040-8428, 18 p.Article

Swedish Association of Urology Annual Spring MeetingMALMSTRÖM, Per-Uno.Scandinavian journal of urology and nephrology. Supplementum. 1998, Vol 197, issn 0300-8886, 16 p.Conference Proceedings

The star chart to Ta bladder cancer: An unsophisticated analysis of two-dimensional gel electrophoresis proteome mapsRØTTERUD, Ranveig; MALMSTRÖM, Per-Uno; WAHLQVIST, Rolf et al.Scandinavian journal of urology and nephrology. 2010, Vol 44, Num 2, pp 76-83, issn 0036-5599, 8 p.Article

The nordic experience of cooperative urinary bladder cancer trialsMALMSTROM, Per-Uno; RINTALA, Erkki; HELLSTEN, Sverker et al.Seminars in urologic oncology. 2001, Vol 19, Num 1, pp 69-70, issn 1081-0943Article

Basoluminal carcinoma : A new biologically and prognostically distinct entity between basal and luminal breast cancerLAAKSO, Mervi; TANNER, Minna; NILSSON, Jonas et al.Clinical cancer research. 2006, Vol 12, Num 14, pp 4185-4191, issn 1078-0432, 7 p., 1Article

Risk Factors of Developing Long-Lasting Breast Pain After Breast Cancer RadiotherapyLUNDSTEDT, Dan; GUSTAFSSON, Magnus; STEINECK, Gunnar et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 1, pp 71-78, issn 0360-3016, 8 p.Article

Combination of the proliferation marker cyclin A, histological grade, and estrogen receptor status in a new variable with high prognostic impact in breast cancerSTRAND, Carina; AHLIN, Cecilia; BENDAHL, Pär-Ola et al.Breast cancer research and treatment. 2012, Vol 131, Num 1, pp 33-40, issn 0167-6806, 8 p.Article

Radiotherapy and tamoxifen after mastectomy in postmenopausal women-20 year follow-up of the south sweden breast cancer group randomised trial ssbcg II:IKILLANDER, Fredrika; ANDERSON, Harald; RYDEN, Stefan et al.European journal of cancer (1990). 2007, Vol 43, Num 14, pp 2100-2108, issn 0959-8049, 9 p.Article

Topoisomerase IIα gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer : Scandinavian breast group trial 9401TANNER, Minna; ISOLA, Forma; WIKLUND, Tom et al.Journal of clinical oncology. 2006, Vol 24, Num 16, pp 2428-2436, issn 0732-183X, 9 p.Article

Physical performance, toxicity, and quality of life as assessed by the physician and the patientLUOMA, Minna-Liisa; HAKAMIES-BLOMQVIST, Liisa; VALVERE, Vahur et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 1, pp 44-49, issn 0284-186XArticle

Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)MAGNUSSON, Marie; HÖGLUND, Peter; JOHANSSON, Karin et al.European journal of cancer (1990). 2009, Vol 45, Num 14, pp 2488-2495, issn 0959-8049, 8 p.Article

Exploring the two-gene ratio in breast cancer-independent roles for HOXB13 and IL17BR in prediction of clinical outcomeJEREVALL, Piiha-Lotta; BROMMESSON, Sara; STRAND, Carina et al.Breast cancer research and treatment. 2008, Vol 107, Num 2, pp 225-234, issn 0167-6806, 10 p.Article

Estrogen receptor β Expression is associated with tamoxifen response in erα-negative breast carcinomaGRUVBERGER-SAAL, Sofia K; BENDAHL, Pär-Ola; FERNÖ, Marten et al.Clinical cancer research. 2007, Vol 13, Num 7, pp 1987-1994, issn 1078-0432, 8 p.Article

The predictive value of Bcl-2, Bax, Bcl-xL, Bag-1, Fas, and FasL for chemotherapy response in advanced breast cancerSJÖSTRÖM, Johanna; BLOMQVIST, Carl; REED, John C et al.Clinical cancer research. 2002, Vol 8, Num 3, pp 811-816, issn 1078-0432Article

Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001GARDMARK, Truls; BLADSTRÖM, Anna; HELLSTEN, Sverker et al.Scandinavian journal of urology and nephrology. 2006, Vol 40, Num 4, pp 276-282, issn 0036-5599, 7 p.Article

High Frequency of Prostate Antigen-Directed T Cells in Cancer Patients Compared to Healthy Age-Matched IndividualsFORSBERG, Ole; CARLSSON, Björn; MALMSTRÖM, Per-Uno et al.The Prostate. 2009, Vol 69, Num 1, pp 70-81, issn 0270-4137, 12 p.Article

Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomySANDBLOM, Gabriel; SORENSEN, Jens; LUNDIN, Niclas et al.Urology (Ridgewood, NJ). 2006, Vol 67, Num 5, pp 996-1000, issn 0090-4295, 5 p.Article

Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and gradeMAHDY, Ensaf; YI PAN; NAINING WANG et al.Anticancer research. 2001, Vol 21, Num 5, pp 3167-3173, issn 0250-7005Article

Randomized phase ii marker lesion study evaluating effect of scheduling on response to intravesical gemcitabine in recurrent stage Ta urothelial cell carcinoma of the bladderGARDMARK, Truls; CARRINGER, Malcolm; BECKMAN, Eva et al.Urology (Ridgewood, NJ). 2005, Vol 66, Num 3, pp 527-530, issn 0090-4295, 4 p.Article

Analysis of HER2 expression in primary urinary bladder carcinoma and corresponding metastasesGARDMARK, Truls; WESTER, Kenneth; DE LA TORRE, Manuel et al.BJU international (Papier). 2005, Vol 95, Num 7, pp 982-986, issn 1464-4096, 5 p.Article

Analysis of progression and survival after 10 years of a randomized prospective study comparing mitomycin-C and bacillus Calmette-Guerin in patients with high-risk bladder cancerGARDMARK, Truls; JAHNSON, Staffan; WAHLQUIST, Rolf et al.BJU international (Papier). 2007, Vol 99, Num 4, pp 817-820, issn 1464-4096, 4 p.Article

A second-look TUR in T1 transitional cell carcinoma: Why? CommentaryJAKSE, Gerhard; ALGABA, Ferran; MALMSTRÖM, Per-Uno et al.European urology. 2004, Vol 45, Num 5, pp 539-546, issn 0302-2838, 8 p.Article

HER-2: A possible target for therapy of metastatic urinary bladder carcinomaWESTER, Kenneth; SJÖSTRÖM, Anna; DE LA TORRE, Manuel et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 3, pp 282-288, issn 0284-186XArticle

  • Page / 3